Blueshift Asset Management »

BioCryst Pharmaceuticals shares owned by Blueshift Asset Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Blueshift Asset Management from 13F filings

Historical chart of Blueshift Asset Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Blueshift Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Blueshift Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $111k 12k 9.52
2021-12-31 $442k 32k 13.85
2021-09-30 $295k 21k 14.35
2021-03-31 $586k 58k 10.16

More positions owned by Blueshift Asset Management

Ishares Tr Russell 2000 Etf (IWM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Etsy (ETSY)
Avis Budget (CAR)
Match Group (MTCH)
O'reilly Automotive (ORLY)
Five Below (FIVE)
Murphy Usa (MUSA)
Equifax (EFX)
CarMax (KMX)
Nike CL B (NKE)
Walt Disney Company (DIS)
Affirm Hldgs Com Cl A (AFRM)
Target Corporation (TGT)
Royal Caribbean Cruises (RCL)

View all positions for Blueshift Asset Management

Top funds holding BioCryst Pharmaceuticals

BlackRock
RA Capital Management
Deerfield Management Company
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
TCG Crossover Management
Henderson Group
Perceptive Advisors
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Kynam Capital Management
Bank of America Corporation
Standard Life Aberdeen

View all funds holding BioCryst Pharmaceuticals